• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素-λ rs12979860基因型与病毒和非病毒慢性肝病中的肝纤维化

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

作者信息

Eslam Mohammed, Hashem Ahmed M, Leung Reynold, Romero-Gomez Manuel, Berg Thomas, Dore Gregory J, Chan Henry L K, Irving William L, Sheridan David, Abate Maria L, Adams Leon A, Mangia Alessandra, Weltman Martin, Bugianesi Elisabetta, Spengler Ulrich, Shaker Olfat, Fischer Janett, Mollison Lindsay, Cheng Wendy, Powell Elizabeth, Nattermann Jacob, Riordan Stephen, McLeod Duncan, Armstrong Nicola J, Douglas Mark W, Liddle Christopher, Booth David R, George Jacob, Ahlenstiel Golo

机构信息

Storr Liver Unit, Westmead Millennium Institute and Westmead Hospital, University of Sydney, Sydney, New South Wales 2145, Australia.

Faculty of Engineering, Department of Systems and Biomedical Engineering, Minia University, Minia 6111, Egypt.

出版信息

Nat Commun. 2015 Mar 5;6:6422. doi: 10.1038/ncomms7422.

DOI:10.1038/ncomms7422
PMID:25740255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4366528/
Abstract

Tissue fibrosis is a core pathologic process that contributes to mortality in ~45% of the population and is likely to be influenced by the host genetic architecture. Here we demonstrate, using liver disease as a model, that a single-nucleotide polymorphism (rs12979860) in the intronic region of interferon-λ4 (IFNL4) is a strong predictor of fibrosis in an aetiology-independent manner. In a cohort of 4,172 patients, including 3,129 with chronic hepatitis C (CHC), 555 with chronic hepatitis B (CHB) and 488 with non-alcoholic fatty liver disease (NAFLD), those with rs12979860CC have greater hepatic inflammation and fibrosis. In CHC, those with rs12979860CC also have greater stage-constant and stage-specific fibrosis progression rates (P<0.0001 for all). The impact of rs12979860 genotypes on fibrosis is maximal in young females, especially those with HCV genotype 3. These findings establish rs12979860 genotype as a strong aetiology-independent predictor of tissue inflammation and fibrosis.

摘要

组织纤维化是一种核心病理过程,约45%的人群死亡与之相关,且可能受宿主基因结构影响。在此,我们以肝病为模型证明,干扰素λ4(IFNL4)内含子区域的单核苷酸多态性(rs12979860)以病因独立的方式,是纤维化的有力预测指标。在一个由4172名患者组成的队列中,包括3129例慢性丙型肝炎(CHC)患者、555例慢性乙型肝炎(CHB)患者和488例非酒精性脂肪性肝病(NAFLD)患者,携带rs12979860CC的患者有更严重的肝脏炎症和纤维化。在CHC患者中,携带rs12979860CC的患者也有更高的分期恒定和分期特异性纤维化进展率(所有P<0.0001)。rs12979860基因型对纤维化的影响在年轻女性中最大,尤其是那些感染丙型肝炎病毒3型的女性。这些发现确立了rs12979860基因型是组织炎症和纤维化的有力病因独立预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0f/4366528/689048490d96/ncomms7422-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0f/4366528/ea4cb109cfab/ncomms7422-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0f/4366528/e627fed220c6/ncomms7422-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0f/4366528/689048490d96/ncomms7422-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0f/4366528/ea4cb109cfab/ncomms7422-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0f/4366528/e627fed220c6/ncomms7422-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0f/4366528/689048490d96/ncomms7422-f3.jpg

相似文献

1
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.干扰素-λ rs12979860基因型与病毒和非病毒慢性肝病中的肝纤维化
Nat Commun. 2015 Mar 5;6:6422. doi: 10.1038/ncomms7422.
2
Interferon-λ rs12979860 genotype association with liver fibrosis in chronic hepatitis C (CHC) patients in the Pakistani population.干扰素-λ rs12979860 基因型与巴基斯坦慢性丙型肝炎(CHC)患者肝纤维化的相关性。
Arch Virol. 2021 Apr;166(4):1047-1056. doi: 10.1007/s00705-020-04901-2. Epub 2021 Feb 2.
3
[Interferon Lambda 4 RS12979860 C>T polymorphism is not associated with liver fibrosis in patients with hepatitis C].[丙型肝炎患者中干扰素λ4基因RS12979860 C>T多态性与肝纤维化无关]
Rev Med Chil. 2018 Jul;146(7):823-829. doi: 10.4067/s0034-98872018000700823.
4
Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.干扰素 lambda 4 rs368234815 TT>δG 变异与非酒精性脂肪性肝病患者的肝损伤有关。
Hepatology. 2017 Dec;66(6):1885-1893. doi: 10.1002/hep.29395. Epub 2017 Nov 6.
5
Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.瞬时弹性成像技术用于检测非酒精性脂肪性肝病和慢性病毒性肝炎纤维化的可靠性。
J Hepatol. 2011 Jan;54(1):64-71. doi: 10.1016/j.jhep.2010.06.022. Epub 2010 Aug 21.
6
The relationship between IFNL4 genotype and the rate of fibrosis in hepatitis C patients.丙型肝炎患者中IFNL4基因分型与纤维化发生率之间的关系。
Scand J Gastroenterol. 2019 Sep;54(9):1172-1175. doi: 10.1080/00365521.2019.1643403. Epub 2019 Sep 3.
7
IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.IFN-λ3 而不是 IFN-λ4 可能介导 IFNL3-IFNL4 单倍型依赖性肝炎症和纤维化。
Nat Genet. 2017 May;49(5):795-800. doi: 10.1038/ng.3836. Epub 2017 Apr 10.
8
The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.膜结合 O-酰基转移酶结构域包含 7 变体 rs641738 增加慢性乙型肝炎的炎症和纤维化。
Hepatology. 2017 Jun;65(6):1840-1850. doi: 10.1002/hep.29064. Epub 2017 Apr 28.
9
Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.慢性乙型肝炎患者与慢性丙型肝炎患者及非酒精性脂肪性肝病患者相比,脂肪变性和胰岛素抵抗的患病率
Eur J Intern Med. 2015 Jan;26(1):30-6. doi: 10.1016/j.ejim.2014.12.001. Epub 2014 Dec 29.
10
Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.供体IFNL4基因型与丙型肝炎受体移植后早期纤维化相关。
PLoS One. 2016 Nov 22;11(11):e0166998. doi: 10.1371/journal.pone.0166998. eCollection 2016.

引用本文的文献

1
Genome-wide meta-analysis identifies nine loci associated with higher risk of hepatocellular carcinoma development.全基因组荟萃分析确定了九个与肝细胞癌发生风险较高相关的基因座。
JHEP Rep. 2025 Jun 11;7(9):101485. doi: 10.1016/j.jhepr.2025.101485. eCollection 2025 Sep.
2
Interferon in Liver Diseases: Recent Advances.肝脏疾病中的干扰素:最新进展
Adv Ther. 2025 Jul 17. doi: 10.1007/s12325-025-03291-8.
3
Interferon lambda 4 is a gut antimicrobial protein.干扰素 lambda 4 是一种肠道抗菌蛋白。

本文引用的文献

1
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.IFNL3 多态性可预测慢性丙型肝炎基因型 2/3 感染的治疗反应。
J Hepatol. 2014 Aug;61(2):235-41. doi: 10.1016/j.jhep.2014.03.039. Epub 2014 Apr 24.
2
Impact of IL28B genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: a meta-analysis.IL28B基因变异对丙型肝炎病毒诱导的肝纤维化、炎症和脂肪变性的影响:一项荟萃分析
PLoS One. 2014 Mar 17;9(3):e91822. doi: 10.1371/journal.pone.0091822. eCollection 2014.
3
Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.
Proc Natl Acad Sci U S A. 2024 Oct 29;121(44):e2409684121. doi: 10.1073/pnas.2409684121. Epub 2024 Oct 22.
4
The Association of Gene Polymorphisms with Hepatitis B Virus (HBV) Infection in the Northern Region of Pará, Brazil.巴西帕拉州北部地区基因多态性与乙型肝炎病毒(HBV)感染的关联。
Int J Mol Sci. 2024 Oct 9;25(19):10836. doi: 10.3390/ijms251910836.
5
Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression.纤维化与肝癌发生:基因-环境相互作用在肝脏疾病进展中的作用。
Int J Mol Sci. 2024 Aug 8;25(16):8641. doi: 10.3390/ijms25168641.
6
A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact.丙型肝炎病毒相关肝细胞癌的遗传学和表观遗传学文献综述:转化影响
Hepatobiliary Surg Nutr. 2024 Aug 1;13(4):650-661. doi: 10.21037/hbsn-23-562. Epub 2024 Apr 18.
7
MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight.MAFLD:理解正常体重个体疾病表型的理想框架。
Ther Adv Endocrinol Metab. 2024 May 27;15:20420188241252543. doi: 10.1177/20420188241252543. eCollection 2024.
8
Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink.代谢功能障碍相关脂肪性肝病与慢性病毒性肝炎:内在联系
Pathogens. 2024 Jan 10;13(1):68. doi: 10.3390/pathogens13010068.
9
Interferon-λ3 rs12979860 can regulate inflammatory cytokines production in pulmonary fibrosis.干扰素-λ3基因rs12979860可调控肺纤维化中炎性细胞因子的产生。
Saudi Pharm J. 2023 Nov;31(11):101816. doi: 10.1016/j.jsps.2023.101816. Epub 2023 Oct 6.
10
Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease.全基因组关联荟萃分析确定了 17 个与非酒精性脂肪性肝病相关的位点。
Nat Genet. 2023 Oct;55(10):1640-1650. doi: 10.1038/s41588-023-01497-6. Epub 2023 Sep 14.
干扰素 lambda 等位基因预测先天抗病毒免疫反应和丙型肝炎病毒的易感性。
Cell Host Microbe. 2014 Feb 12;15(2):190-202. doi: 10.1016/j.chom.2014.01.007.
4
Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C.治疗失败可能导致慢性丙型肝炎患者的纤维化进展加速。
J Viral Hepat. 2014 Feb;21(2):111-20. doi: 10.1111/jvh.12127. Epub 2013 Aug 27.
5
The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs.有利的 IFNL3 基因型可逃避 AU 富含元件和丙型肝炎病毒诱导的 microRNAs 介导的 mRNA 衰变。
Nat Immunol. 2014 Jan;15(1):72-9. doi: 10.1038/ni.2758. Epub 2013 Nov 17.
6
Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway.人类单核苷酸多态性将炎症和传染病的不同结果与 FOXO3 调节的途径联系起来。
Cell. 2013 Sep 26;155(1):57-69. doi: 10.1016/j.cell.2013.08.034. Epub 2013 Sep 12.
7
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection.女性性别、病毒基因型和 IL28B 基因型对急性丙型肝炎病毒感染自发清除的影响。
Hepatology. 2014 Jan;59(1):109-20. doi: 10.1002/hep.26639. Epub 2013 Nov 22.
8
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.IL28B 的表达取决于一种新的 TT/-G 多态性,这种多态性提高了 HCV 清除的预测效果。
J Exp Med. 2013 Jun 3;210(6):1109-16. doi: 10.1084/jem.20130012. Epub 2013 May 27.
9
Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis.IL28B 基因型与慢性丙型肝炎患者纤维化进展和临床结局的关系:一项纵向分析。
Hepatology. 2013 Nov;58(5):1548-57. doi: 10.1002/hep.26506. Epub 2013 Sep 30.
10
IL28B genotype and the expression of ISGs in normal liver.IL28B 基因型与正常肝脏中 ISGs 的表达。
Liver Int. 2013 Aug;33(7):991-8. doi: 10.1111/liv.12148. Epub 2013 Mar 24.